v2.8.0

This version focuses on expanded support for new regulatory authorities, email address login support, and enhancements to group policy features for administrators.

New Features

Support for New Regulatory Authorities and Regions

eCTD v3.2.2 submissions from the following 3 countries can now be viewed in Power Viewer.

Country	Regulatory Authority
Thailand	Food and Drug Administration (FDA Thailand)
South Korea	Ministry of Food and Drug Safety (MFDS)
South Africa	South African Health Products Regulatory Authority (SAHPRA)

Key Benefits

• Submission data for regulatory authorities in Asia and Africa can now be viewed directly in Power Viewer
• Expands the scope of use for organizations pursuing global drug development

Email Address Login Support (Free Plan)

Users on the free plan can now sign in using an email address and one-time password (OTP), in addition to Microsoft and Google accounts.

Enter your email address at login and a 6-digit verification code will be sent to that address. Simply enter the code to complete sign-in.

Key Benefits

• Power Viewer can be tried for free using only an email address, even without a Microsoft or Google account
• No new account registration is required

Admin Feature Enhancements (Group Policy)

New items have been added to the settings controllable via the group policy file.

New Policy Settings

Setting	Description
Lock PDF Engine	Standardizes the PDF display engine used across the entire organization
Override UserRoot	Forces a root folder to be used organization-wide when resolving relative paths

Key Benefits

• The PDF display method can be unified to match the organization’s environment, ensuring consistent rendering
• In deployments using network drives, file path references can be controlled from the administrator side

Improved Behavior When No Connection Settings Exist in the Group Policy File

If no HTTP connection settings are specified in the group policy file, the default settings (no proxy, direct connection) are now applied automatically.

Bug Fixes

Fixed an issue where submission information in Australian (TGA) eCTD could not be read correctly

Fixed an issue where application numbers and sequence numbers in eCTD files submitted to Australia’s Therapeutic Goods Administration (TGA) were not correctly recognized in some cases.

Fixed an issue where some application numbers in EU (EMA) eCTD were not recognized

Fixed an issue where data created in older formats or submission IDs in UUID format for European Medicines Agency (EMA) eCTD were not correctly recognized in some cases.

Notice

• In this version, the license key format has been renewed. License keys in the old format can no longer be used.